EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Transplantation of Wild-Type Hematopoietic Stem and Progenitor Cells Improves Disease Phenotypes in a Mucopolysaccharidosis IIIC Mouse Model

Rafael A Badell-Grau iD, Kasra Pakravesh, Kevin Eric Thai, Frankie Son, Rola Chen, Joseph Rainaldi iD, Kalvin Duong, Pauline Losay, Anusha Sivakumar, Veenita Khare, Alexis N Corl, Rushil Pithia und 3 weitere

Cell Transplantation · 2025

DOI: 10.1177/09636897251323966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Transplantation, 2025. Verfasst von Rafael A Badell-Grau und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Mucopolysaccharidosis III, Hematopoietic Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, Cure Sanfilippo Foundation, National MPS Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucopolysaccharidosis type IIIC (MPS IIIC) is a severe neurodegenerative lysosomal storage disease caused by the loss-of-function of the lysosomal transmembrane protein acetyl-CoA: heparan-α-glucosamine N -acetyltransferase. MPS IIIC is characterized by the accumulation of the glycosaminoglycan (GAG) heparan sulfate. There is no treatment for this disease. We generated a new MPS IIIC mouse model and confirmed disease phenotypes such as GAG accumulation, splenomegaly, neurological defects, and presence of disease-specific non-reducing end carbohydrates. To explore a new therapeutic strategy for this condition, we transplanted wild-type (WT) hematopoietic stem and progenitor cells (HSPCs) into lethally irradiated 2-month-old Hgsnat −/− mice and analyzed the resulting impact 6 months later. Transplanted HSPCs differentiated into macrophages in tissues and microglia-like cells in the brain. This resulted in a partial restoration of Hgsnat expression and enzymatic activity along with a significant reduction of the MPS IIIC-specific non-reducing end carbohydrate in the treated Hgsnat −/− mice compared to untreated Hgsnat −/− mice or Hgsnat −/− mice transplanted with Hgsnat −/− HPSCs. In addition, WT HSPC transplant resulted in improved neurological defects, reduction in splenomegaly, and urine retention in the Hgsnat −/− mice. Furthermore, presence of glomerular hyaline bodies with focal fibrosis and sclerosis was observed in the kidney of the disease controls, whereas these abnormalities were improved in the Hgsnat −/− mice treated with WT HSPCs. These data support that HSPC transplantation presents a promising therapeutic avenue for MPS IIIC and represents the first step toward the clinical translation of an HSPC-mediated therapy strategy for MPS IIIC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationMucopolysaccharidosis IIIHematopoietic Stem CellsAnimalsDisease Models, AnimalMicePhenotypeMice, Inbred C57BLMice, KnockoutGlycosaminoglycansAcetyltransferasesCell Differentiation

Stichwörter der Autor:innen

Sanfilippo syndromeglycosaminoglycans (GAGs)hematopoietic stem and progenitor cells (HSPCs)heparan sulfate (HS)lysosomal storage disorder (LSD)macrophagesmicrogliatransmembrane lysosomal protein

Substanzen

GlycosaminoglycansAcetyltransferases

Autor:innen und Institutionen

  • Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA.
  • Department of Cellular & Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.
  • Division of Genetics, Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA.

ORCID-Profile: Rafael A Badell-Grau, Joseph Rainaldi, Stephanie Cherqui

Förderung

  • NINDS NIH HHS
  • Cure Sanfilippo Foundation
  • National MPS Society

Zitieren

APA

Badell-Grau, R. A., Pakravesh, K., Thai, K. E., Son, F., Chen, R., Rainaldi, J., Duong, K., Losay, P., Sivakumar, A., Khare, V., Corl, A. N., Pithia, R., Tran, C., Esko, J. D., & Cherqui, S. (2025). Transplantation of Wild-Type Hematopoietic Stem and Progenitor Cells Improves Disease Phenotypes in a Mucopolysaccharidosis IIIC Mouse Model. Cell Transplantation. https://doi.org/10.1177/09636897251323966

Vancouver

Badell-Grau RA, Pakravesh K, Thai KE, Son F, Chen R, Rainaldi J, et al. Transplantation of Wild-Type Hematopoietic Stem and Progenitor Cells Improves Disease Phenotypes in a Mucopolysaccharidosis IIIC Mouse Model. Cell Transplantation. 2025. doi:10.1177/09636897251323966

BibTeX
@article{BadellGrau2025,
  author = {Badell-Grau, Rafael A and Pakravesh, Kasra and Thai, Kevin Eric and Son, Frankie and Chen, Rola and Rainaldi, Joseph and Duong, Kalvin and Losay, Pauline and Sivakumar, Anusha and Khare, Veenita and Corl, Alexis N and Pithia, Rushil and Tran, Christine and Esko, Jefferey D and Cherqui, Stephanie},
  title = {Transplantation of Wild-Type Hematopoietic Stem and Progenitor Cells Improves Disease Phenotypes in a Mucopolysaccharidosis IIIC Mouse Model},
  journal = {Cell Transplantation},
  year = {2025},
  doi = {10.1177/09636897251323966}
}
Kostenlos starten →